Depression as adverse effect of Hormonal contraception

Key points
- Few studies focused on the depressogenic properties of the hormonal contraceptives(HC) in spite of diffuse concern about mood changes(1).
- Furthermore, the percentage of women who reported depressive symptoms seems to decline as the number of years of HCs use increase (3).
- Cognitive –emotional factors including the appraisal of stress, loci of control and self-integration were implicated with specific patterns of negative affect and much more so for users than for nonusers (5).
- A study carried by Parry in 2001 hypothesized that changing reproductive hormones, by affecting the synchrony or coherence between components of the circadian system,may alter amplitude or timing relationships and thereby contribute to the development of mood disorders in predisposed individuals(6).
Few studies focused on the depressogenic properties of the hormonal contraceptives(HC) in spite of diffuse concern about mood changes(1). Several years ago,it was affirmed that most women using combined oral contraceptives(COCs) can expect minimal change in mood(2).
Furthermore, the percentage of women who reported depressive symptoms seems to decline as the number of years of HCs use increase (3). Impairment of social functioning is a significant aspect of depression distinct from the symptoms of depression (4).
Cognitive –emotional factors including the appraisal of stress, loci of control and self-integration were implicated with specific patterns of negative affect and much more so for users than for nonusers (5).
A study carried by Parry in 2001 hypothesized that changing reproductive hormones, by affecting the synchrony or coherence between components of the circadian system,may alter amplitude or timing relationships and thereby contribute to the development of mood disorders in predisposed individuals(6). It is known that neuroactive steroids as the gamma-aminobutyric acid receptor agonists are important in the modulation of affect and adaptation to stress(7).
A recent study reported that healthy women without underlying mood or anxiety disorder who were given a low-dose combined oral contraceptives did not experience adverse psychological symptoms despite a significant reduction in neuroactive steroids. Women have the greatest risk for developing depressive disorders compared with men.
In addition several biological conditions may be involved in the predisposition of women to depression, including genetically determined vulnerability, hormonal fluctuations, and a particular sensitivity to such hormonal fluctuations in brain systems that mediate depressive states. Although considering cognitive-emotional functioning for HCs users and non users seems that the use may influence the saliency rather than the nature of cognitive-emotional pattern (5).
{embed="ref/stat-menu-obgyn3"}
Relational events as role-stress, sex-specific socialization and disadvantaged social status have been considered to be contributors to the increased vulnerabiliuty of women to depression.
In addition,it is known that a higher proportion of housewives than women going out to full-time work show depressive symptoms. It is hypothesized that several reproductive events may be related to depression as: premenstrual dysphoric disorder, pregnancy, post-partum, menopause, miscarriage, infertility, hormone replacement therapy and hormonal contraceptive use (8,9).
A recent study performed on adolescent girls treated with depot-medroxyprogesterone acetate (DPMA) over a period of 12 months, showed that those do not present depressive symptoms .
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Women's Health →
GuideColorectal cancer risk of Hormonal Contraception
The association between oral contraceptive use and colorectal cancer have yielded conflicting results. The analysis from a multicenter case-control study, conducted in 6 Italian regions in 1992-96 with data from a…
8 June 2010
GuideCervical cancer risk of Hormonal Contraception
In some studies HCs have been associated with an increased risk of cervical abnormalities and cervical cancer, but there might be alternative explanations for these epidemiological associations: HC users can start…
8 June 2010
GuideEndometrial cancer risk of Hormonal Contraception
Combination oral contraceptive use was associated with a decreased risk in endometrial carcinoma, which decrease with duration of use (RR=0.28 at 5 years of use); however, the estimated protective effect was reduced and…
8 June 2010



